Fig. 3From: Artificial intelligence for the diagnosis of clinically significant prostate cancer based on multimodal data: a multicenter studyThe diagnostic performance AUC of AutoML outperformed PSA, fPSA/tPSA, and SOC in an internal validation cohort and two prospective cohorts, Chinghai and Zhongdu. AUC, area under the curve; AutoML, automated machine learning; PSA, prostate cancer-specific antigen; SOC, standard of careBack to article page